¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦42Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãá°èÇмú´ëȸ 밎 Á¦16Â÷ ±¹Á¦½ÉÆ÷Áö¾ö (KCR2022) 3ÀÏÂ÷ : 2022-05-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦42Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãá°èÇмú´ëȸ 밎 Á¦16Â÷ ±¹Á¦½ÉÆ÷Áö¾ö (KCR2022) 3ÀÏÂ÷ : 2022-05-21
±³À°ÀÏÀÚ : 2022-05-21
±³À°Àå¼Ò : µå·¡°ï½ÃƼ (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)  
±³À°ÁÖÁ¦ : Á¦42Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãá°èÇмú´ëȸ 밎 Á¦16Â÷ ±¹Á¦½ÉÆ÷Áö¾ö (KCR2022) 3ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630  
À̸ÞÀÏ : webmaster@rheum.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ¿µ»óÀÇÇаú, ÀçÈ°ÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 18 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í È¸¿ø Àü¹®ÀÇ 120,000¿ø, ȸ¿ø Àü°øÀÇ 60,000¿ø ºñȸ¿ø Àü¹®ÀÇ 150,000¿ø, ºñȸ¿ø Àü°øÀÇ 80,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-21 ROOM A 08:00~08:40 Biosimilar: Past, present and future  È«½ÂÀç(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM A 09:00~10:00 The future of rheumatology  Antony Rosen(Johns Hopkins, USA) 
±³À°½Ã°£ 05-21 ROOM A 10:30~11:00 Hype and truth - treatment paradigm of osteoarthritis  David Hunter(Univ. of Sydney, Australia) 
±³À°½Ã°£ 05-21 ROOM A 11:00~11:30 Addicted to preion, medical abuse of osteoarthritis  Yuqing Zhang(Massachusetts General Hosp., USA) 
±³À°½Ã°£ 05-21 ROOM A 11:30~12:00 Use or abuse? APM for degenerative meniscus in osteoarthritis  ±èÇö¾Æ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM A 12:00~12:40 The role of IL-17A in axial spondyloarthritis and axial PsA  Matthew Brown(Kings College London, UK) 
±³À°½Ã°£ 05-21 ROOM A 13:00~13:30 Synovial macrophages as gatekeepers of inflammation  Gerhard Krönke(Alexander Univ. Erlangen, Germany) 
±³À°½Ã°£ 05-21 ROOM A 13:30~14:00 Notch signalling drives synovial fibroblast identity and arthritis pathology  Soumya Raychaudhuri(Brigham and Women¡¯s Hosp. and Harvard Medical School, USA) 
±³À°½Ã°£ 05-21 ROOM A 14:00~14:30 Roles of stromal cells and potential significance for future therapy in RA  ÀÌ»óÀÏ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM A 15:30~16:00 Update in the pathogenesis of systemic sclerosis  Christopher Denton(Royal Free Hosp., UK) 
±³À°½Ã°£ 05-21 ROOM A 16:00~16:30 Update in interstitial lung disease in SSc  Oliver Distler(Univ. Hosp. Zurich, Switzerland) 
±³À°½Ã°£ 05-21 ROOM A 16:30~17:00 Update in pulmonary arterial hypertension in SSc  ÀÌÀººÀ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 08:00~08:40 IL-17 inhibition in spondyloarthritis: The efficacy of Ixekizumab and clinical relevance  ÀÌ¿¬¾Æ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 10:30~12:00 Free Paper Session – Spondyloarthritis  ±¸¿¬(¹ßÇ¥ ¼¼¼Ç) 
±³À°½Ã°£ 05-21 ROOM B 12:00~12:40 Denosumab key clinical questions  ±è¼º¼ö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 13:00~13:30 Anabolic therapy for osteoporosis  ±èÇÏ¿µ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 13:30~14:00 Ideal sequential therapy in osteoporosis management  ±è°æ¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 14:00~14:30 Prevention and treatment of fracture in RA  ¹ÎÁرâ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM B 15:30~17:00 Free Paper Session – Rheumatoid Arthritis Basic Research  ±¸¿¬(¹ßÇ¥ ¼¼¼Ç) 
±³À°½Ã°£ 05-21 ROOM C 08:00~08:40 Long-lasting Golimumab in AS: Learnings real-world evidence  ±¸º»»ê(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM C 10:30~12:00 Free Paper Session – Systemic Lupus Erythematosus  ±¸¿¬(¹ßÇ¥ ¼¼¼Ç) 
±³À°½Ã°£ 05-21 ROOM C 12:00~12:40 Tacrolimus in rhematoid arthritis  ÃÖÂù¹ü(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM C 13:00~14:30 Free Paper Session – Vasculitis and Metabolic Bone Disease  ±¸¿¬(¹ßÇ¥ ¼¼¼Ç) 
±³À°½Ã°£ 05-21 ROOM C 15:30~16:00 Rheumatic diseases and KCD 8th revision  ±è¼®ÀÏ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-21 ROOM C 16:00~16:30 Principles and future prospects of insurance benefits in rheumatoid diseases  ¼­±âÇö(°Ç°­º¸Çè½É»çÆò°¡¿ø) 
±³À°½Ã°£ 05-21 ROOM C 16:30~17:00 Insurance guideline and tips for treatment of rheumatic disease  È«½ÂÀç(°æÈñÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦42Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãá°èÇмú´ëȸ 밎 Á¦16Â÷ ±¹Á¦½ÉÆ÷Áö¾ö (KCR2022) 3ÀÏÂ÷ : 2022-05-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2022-05-21
´ÙÀ½±Û Á¦52ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ day2 : 2022-05-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 4 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 8 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 9 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 8 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 5 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 8 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 9 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 9 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 5 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 2 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 4 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 8 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 3 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 4 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 5 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷